Perfluorobutanesulfonate (PFBS) is widely used in many industrial products. We evaluated the influence of prenatal PFBS exposure on perinatal growth and development, pubertal onset, and reproductive and thyroid endocrine system in female mice. Here, we show that when PFBS (200 and 500 mg/kg/day) was orally administered to pregnant mice (PFBSdams) on days 1-20 of gestation; their female offspring (PFBS-offspring) exhibited decreased perinatal body weight and delayed eye opening compared with control offspring. Vaginal opening and first estrus were also significantly delayed in PFBS-offspring, and diestrus was prolonged. Ovarian and uterine size, as well as follicle and corpus luteum numbers, were reduced in adult PFBS-offspring. Furthermore, pubertal and adult PFBS-offspring exhibited decreases in serum estrogen (E2) and progesterone (P4) levels with the elevation of luteinizing hormone levels. Notably, decreases in serum total thyroxine (T4) and 3,3 0 , 5-triiodothyronine (T3) levels were observed in fetal, pubertal, and adult PFBS-offspring in conjunction with slight increases in thyroid-stimulating hormone (TSH) and thyrotropin-releasing hormone levels. In addition, PFBS-dams exhibited significant decreases in total T4 and T3 levels and free T4 levels and increases in TSH levels, but no changes in E2 and P4 levels. These results indicate that prenatal PFBS exposure (!200 mg/kg/day) causes permanent hypothyroxinemia accompanied by deficits in perinatal growth, pubertal onset, and reproductive organ development in female mice.
Perfluoroalkyl substances (PFASs) have been used in many industrial products, such as lubricants, firefighting foams, coating additives, and stain-resistant materials, as well as manufacturing processes such as electroplating, for > 60 years (Prevedouros et al., 2006) . The serum elimination half-life of perfluorobutanesulfonate (PFBS, C 4 F 9 SO 3 -) has been calculated to have a geometric mean of 25.8 days, whereas that of perfluorooctanesulfonate (PFOS, C 8 F 17 SO 3 -) has been calculated to be 4.8 years (Olsen et al., 2009) . Perfluorobutanesulfonate has been used as a substitute compound for PFOS in recent years (Persson et al., 2013) , leading to rapid increases in its production (Oliaei et al., 2013) . Perfluorobutanesulfonate is released directly into the environment during the manufacture and use of perand poly-fluoroalkyl substances (Buck et al., 2011) . In addition, PFBS is a degradation product of and a potential impurity in perfluoroalkanesulfonyl-based electrochemical fluorination products. High PFBS concentrations have been measured in Germany (Eschauzier et al., 2012; Moller et al., 2010) , China (Zhang et al. 2013; Zhu et al., 2015) , and Antarctica (Wei et al., 2007) .
As PFBS is widely used, PFBS-induced adverse effects and developmental toxicity have recently attracted much attention. For example, PFBS administration to rats has been shown to be associated with reductions in red blood cell counts, hemoglobin concentrations, and hematocrit (Lieder et al., 2009a) . Lieder et al. (2009b) observed that the number of female rats exhibiting diestrus prolongation increases significantly following perinatal exposure to PFBS (100 mg/kg/day). Parental exposure to PFBS at a dose of 1000 mg/kg/day has been shown to cause reductions in terminal body weight (BW) and slight delays in preputial separation (approximately 2 days) in male offspring of rats (Lieder et al., 2009b) . However, the influence of the prenatal exposure to PFBS on fetal growth, pubertal development, and adult reproductive function still remains unclear.
The association between maternal PFASs exposure and thyroid hormone status has been reported in pregnant women and neonates (Yang et al., 2016) . The exposure to some PFASs during pregnancy has been associated with lower total triiodothyronine (T3) and total thyroxine (T4) levels in pregnant women and fetuses (Wang et al., 2014) . A large body of evidence indicates that PFOS exposure can reduce circulating thyroid hormones in monkeys, rats, and mice (Seacat et al., 2002; Thibodeaux et al., 2003; Yu et al., 2009a) . Perfluorooctanesulfonate increases the hepatic uridine diphosphoglucuronosyl transferase 1A and thyroidal type 1 deiodinase expression (Yu et al., 2009b) through peroxisome proliferator-activated receptor a (PPARa) activation (Shipley et al., 2004; Wolf et al., 2008) . Similarly, PFBS can increase the activity of PPARa in mice and humans (Wolf et al., 2008) . Little is known, however, about the influence of the prenatal exposure to PFBS on offspring thyroid development and function.
Several lines of evidence suggest that maternal thyroid hormone levels during pregnancy play critical roles in offspring growth and development in rodent models. The long-term impact of low maternal thyroid function during pregnancy on childhood development is well known (Nazarpour et al., 2015) . Childhood thyroid function is determined primarily by maternal thyroid hormone levels (Korevaar et al., 2016) . Maternal hypothyroxinemia can affect neonatal thyroid development (Burrow et al., 1994) . Prepubertal thyroid hormone insufficiency is reportedly associated with delayed pubertal onset and sexual maturation in female rats and humans (Larsen et al., 1998) .
In this study, we investigated the influence of exposure to PFBS (50, 200, and 500 mg/kg) during gestation on perinatal growth and development, pubertal onset, and reproductive and thyroid endocrine system in female mice.
MATERIALS AND METHODS

Animals
This study was approved by the Animal Care and Ethics Committee of Nanjing Medical University. All animal handling procedures followed the guidelines of the Institute for Laboratory Animal Research of Nanjing Medical University. Twelve-week-old female (32-34 g) and male (35-38 g) ICR mice were obtained from Oriental Bio Service Inc. (Nanjing, Jiangsu, China). All mice were housed in stainless steel cages with wood bedding to minimize additional exposure to endocrinedisrupting chemicals (temperature 23 6 2 C, humidity 55 6 5%, and 12 h light:12 h darkness cycle) in the Animal Research
Center of Nanjing University. The mice had free access to food and water, the latter of which was provided in a glass bottle.
PFBS Administration
PFBS potassium salt (K þ PFBS) was purchased from SigmaAldrich (CAS#29420-49-3; St. Louis, Missouri; 98% purity). Perfluorobutanesulfonate solutions were prepared in 0.1% carboxymethyl cellulose using reverse osmosis-processed deionized water (Lieder et al., 2009b) . Estrous cyclicity was monitored daily at 0800-0900 via vaginal cytology evaluations. Vaginal plug detection was chosen to indicate gestational day (GD) 1. Pregnant mice were housed individually in nesting boxes and administered PFBS orally at doses of 50, 200, and 500 mg/kg/day in a volume of 150 ll from GD1 to GD20. Dosages were adjusted daily for BW changes. Perfluorobutanesulfonate doses were chosen based on the results of a recent study in adult female rats (Lieder et al., 2009a) In this study, 30 dams in each dose group were randomly assigned to one of the following 3 experimental groups: group 1, in which perinatal survival and growth, pubertal onset, and ovarian and uterine development were sequentially examined in the same cohorts (50 offspring/10 dams); group 2, in which hypothalamic-pituitary-gonadal hormone and hypothalamicpituitary-thyroid hormone levels were measured in PND1 offspring (n ¼ 30), PND30 offspring (n ¼ 10), and PND60 offspring (n ¼ 10) obtained from 10 dams; and group 3, in which the levels of serum PFBS were measured (n ¼ 10 dams).
Perinatal Growth and Development
The numbers and BWs of live pups were checked daily beginning on PND1. Eye opening time was examined beginning on PND12.
Puberty Onset and Estrous Cycle
Puberty onset was determined by tracking vaginal opening, beginning on PND24. After the vaginal opening was observed, the first estrus and the estrous cycles were sequentially monitored daily from 0800 to 0900 by vaginal cytology evaluations, according to the method described by Cooper et al. (1999) . The estrous cycle stages were defined as proestrus (nucleated or nucleated/ cornified cells), estrus (cornified cells), and diestrus (leukocytes or leukocytes/nucleated cells). The days of proestrus, estrus, and diestrus on each estrous cycle were examined from PND40 to PND60 and averaged to obtain the values per mice. Then, these values per experimental group were further averaged to provide the mean value of proestrus, estrus, and diestrus.
Ovarian and Uterine Morphology
Adult (PND60) mice at diestrus were euthanized with pentobarbital (3 mg/100 ml, IP). Their ovaries and uteri were dissected and weighed and then fixed in Bouin's fluid. After dehydration through a graded ethanol series, the samples were processed for paraffin embedding and then serially cut. The sections (5 lm) were deparaffinized and rehydrated and then stained with hematoxylin and eosin (HE). Follicles were counted using a conventional light microscope (Olympus DP70, Japan) with a Â40 objective. Follicles (primordial, primary, secondary, early antral, antral, and preovulatory) and corpora lutea in every sixth section (30 lm apart) were counted by 2 observers in a blinded fashion, as described elsewhere (Glidewell-Kenney et al., 2007) . The obtained results were multiplied by 6 to give the total numbers of follicles and corpora lutea in each ovary. Only follicles containing an oocyte with a visible nucleus were counted to avoid double-counting. Follicular stages were classified using morphological criteria described elsewhere (Myers et al., 2004) . Early antral follicles generally possessed only 1 or 2 small follicular fluid (antrum) areas, whereas antral follicles possessed a single large antral space. Preovulatory follicles were the largest follicular type and possessed a defined cumulus granulosa cell layer, as well as a rim of cumulus cells surrounding the oocyte. One uterine horn per mouse was separated into equal proximal, middle, and distal segments. Fifteen slides of the uterine were prepared from tissue sections (5 lm) obtained from the middle segment (2 mm) via harvesting from every 20th section (100 lm apart). The thicknesses (lm) of the uterus, endometrium (from the luminal surface to the stroma-muscle border), and myometrium were measured in 2 different fields in each slide using computer software (Marzieh et al., 2015) . The data were averaged to obtain the mean thicknesses of the uterus, endometrium, and myometrium in each mouse.
Hormone Measurements
Orbital blood was obtained from PND30/PND60 offspring and GD20 dams under pentobarbital (3 mg/100 ml, IP)-induced anesthesia. Blood was collected from PND1 offspring via decapitation. The serum was separated by centrifugation at 4 C and stored at À80 C until assay. Mice brains were removed quickly under pentobarbital (3 mg/100 ml, IP)-induced anesthesia. The hypothalamus was microdissected and homogenized in phosphate buffered saline (pH 7.1, 400 ll) and then centrifuged at 5000 rpm/4 min at 4 C. These hypothalamus samples were stored at À80 C until assay. Total thyroxine (T4) and 3,3 0 ,5-triiodothyronine (T3), free T4, thyroid-stimulating hormone (TSH), estrogen (E2), luteinizing hormone (LH), progesterone (P4), and gonadotropin-releasing hormone (GnRH) levels were measured using commercial ELISA kits (Uscn Life Science Inc., Houston), according to the manufacturer's instructions. The sensitivities were 1.4 ng/ml for total T4, 47.1 pg/ml for total T3, 0.2 ng/dl for free T4, 19.3 pg/ml for TSH, 2.0 pg/ml for E2, 0.2 ng/ml for LH, 5.2 pg/ml for GnRH, and 0.2 ng/ml for P4. The intra-and interassay. coefficients of variation were 4.3% and 7.5% for total T4, 4.5% and 7.2% for total T3, 4.6% and 6.3% for free T4, 3.2% and 9.5% for TSH, 6.0% and 5.8% for E2, 5.5% and 8.9% for LH, 2.1% and 6.3% for GnRH, and 5.8% and 8.4% for P4.
PFBS Measurement
The serum was separated by centrifugation at 4 C and stored at À80 C until assay. The initial extraction was based on 100-ll serum, 10-ll internal standard solution (containing PFBS). Then, 150-ll methanol was added in the primary extraction tube and briefly mixed by vortexing for 30 s. After the addition of the 150 ll 1% acetonitrile for protein precipitation, the primary extraction tubes were shaken on a mechanical shaker for 20 min and then centrifuged at 12 000 Â g for 10 min. The supernatant was decanted to a clean, labeled tube and then 150-ll acetonitrile was added and stored at 20 C for 1 h. After the supernatant was transferred into a high-performance liquid chromatography (HPLC) glass vial, 2 mM ammonia acetate buffer solution (350 ll) was added. A stock solution (1 ng/ll) was diluted with methanol/water (50/50, vol/vol) to obtain the standard mix working solutions. Perfluorobutanesulfonate was eluted from the SPE cartridge with 2-ml methanol and analyzed by HPLCelectrospray tandem mass spectrometry.
Reverse Transcription and Quantitative Polymerase Chain Reaction
Total RNA was extracted from the hypothalamus samples using the Trizol reagent (Invitrogen, Carlsbad, California), according to the manufacturer's instructions. Purified RNA with an A260/ A280 ratio of 1.8-2.0 was used. RNA (1 lg) was reversed transcribed into cDNA using a reverse transcription kit (TaKaRa Biotechnology CO., Ltd). A Light Cycler Fast Start DNA Master SYBR Green I Kit and an ABI Prism 7300 Sequence Detection System (Applied Biosystems, Foster City, California) were used for the polymerase chain reaction (PCR) reactions. The transcript copy numbers were calculated relative to the parallel amplification of known concentrations of each cloned PCR fragment. Standard curves were constructed, and the amplification efficiencies were ranged between 0.9 and 0.95. The following primers were chosen to generate the PCR fragments: Trh, 5 0 -CCC AGCCAGTTTGCACTCTT-3 0 and 5 0 -AGATCAAAGCCAGAGCCATC A-3 0 ; and GAPDH, 5 0 -GGAGAAACCTGCCAAGTA-3 0 and 5 0 -AAGAG TGGGAGTTGCTGTTG-3 0 (Cheng et al., 2011) . Relative gene expression was determined using the 2-DDct method, with normalization to GAPDH expression. Based on melting curve analyses, only 1 PCR product was amplified for each set of primers.
Data/Statistical Analysis
Group data are expressed as the mean 6 (SE. All statistical analyses were performed using SPSS software, version 16.0 (SPSS Inc., Chicago, Illinois). Differences among means were analyzed using 1-/2-factor ANOVA followed by Bonferroni's post hoc analysis. P < .05 and P < .01 were considered statistically significant.
RESULTS
Prenatal Exposure to PFBS Affects Growth of Female Offspring
Female mice were orally administered PFBS (50, 200, and 500 mg/kg/day) on GD1-20 (PFBS-dams). Their female offspring (PFBS-offspring) were born alive and were pink in color. The numbers of neonatal PFBS-offspring in the 50 mg/kg (9.8 6 0.51, n ¼ 10 dams), 200 mg/kg (11.5 6 0.54, n ¼ 10 dams), and 500 mg/kg (12.1 6 0.57, n ¼ 10 dams) dosage groups were not significantly different from that in the control group (10.8 6 0.63; P > 0.05; n ¼ 10 dams). All PFBS-offspring appeared to be active and survived until adulthood. As shown in Figure 1A , the BWs of PND1 female PFBS-offspring in the 200 mg/kg (P < .05, n ¼ 50 pups/10 dams) and 500 mg/kg dosage groups (P < .05, n ¼ 50/10), but not in the 50 mg/kg dosage group (P > .05, n ¼ 50/10), were lower than those in the control group. Compared with control offspring, these PFBS-offspring remained underweight throughout the weaning (P < .01, n ¼ 40/10; Figure 1A ), pubertal (P < .01, n ¼ 40/10; Figure 1B ) and adult periods (data not shown).
Prenatal Exposure to PFBS Delays Development and Pubertal Onset
The majority of control offspring opened their eyes during PND14-15 (n ¼ 50/10; Table 1 ). However, a slight but significant delay (of approximately 1.5-2 days) in eye opening was observed in PFBS-offspring (200/500 mg/kg) compared with control offspring (P < .01, n ¼ 50/10). Vaginal opening occurred on PND26-27 (n ¼ 30/10) in control offspring. By contrast, PFBS-offspring (200/500 mg/kg) exhibited delayed vaginal opening (P < .01, n ¼ 30/10). The first estrus was observed on days 1-2 after vaginal opening in the majority of control offspring (n ¼ 30/10). However, the first estrus was delayed up to 5 days in PFBS-offspring (200/500 mg/kg) (P < .01, n ¼ 30/10).
Prenatal Exposure to PFBS Impairs Ovarian and Uterine Development
The sizes of the ovaries of PND60 PFBS-offspring (200/500 mg/ kg) were smaller than those of control offspring (n ¼ 10/10; Figure 2A ), and the relative weights (% BW) were lower (P < .05, n ¼ 30/10; Figure 2B ). Perfluorobutanesulfonate-offspring (200/ 500 mg/kg) (P < .05, n ¼ 10/10; Table 2 ) exhibited fewer primordial follicles, primary follicles, secondary follicles, early antral follicles, antral follicles and preovulatory follicles, as well as fewer corpora lutea (P < .05, n ¼ 10/10) than control offspring at diestrus. Perfluorobutanesulfonate-offspring (200/500 mg/kg) exhibited obvious decreases in uterine size (n ¼ 10/10; Figure 2C ) and relative weight (% BW) (P < .01, n ¼ 30/10; Figure 2D ) compared with control offspring, whereas PFBS-mice (50 mg/kg) exhibited (P > .05, n ¼ 30/10) no changes in these parameters. Total uterine section diameter (P < .01, n ¼ 10/10; Table 2 ) and endometrial (P < .05) and myometrial thickness (P < .05) were significantly reduced in PFBS-offspring (200/500 mg/kg) compared with control offspring at diestrus.
Prenatal Exposure to PFBS Affects Estrous Cycles and Reproductive Hormones
Generally, repeated 1-day proestrus (P), 1-day estrus (E), and 1-2-day diestrus (D) cycles were observed in PND40-60 control offspring, which were called "regular cyclers" ( Figure 3A) . Notably, PND40-60 PFBS-offspring (200/500 mg/kg) exhibited a prolongation of diestrus compared with control (P < .05, n ¼ 30/10). To explore the endocrine pathways underlying PFBS-induced impairments in growth and development and pubertal onset, we examined hypothalamic-pituitary-gonadal hormone levels in neonatal (PND1, n ¼ 30/10), pubertal (PND30, n ¼ 10/10), and adult (PND60, n ¼ 10/10) diestrus PFBS-offspring. Compared with control offspring, PND30 PFBS-offspring (200/500 mg/kg) (P < .05; Figure 3B ) and PND60 PFBS-offspring (200/500 mg/kg) exhibited reduced serum E2 levels (P < .05). A slight increase in the level of serum LH was observed in PND30 PFBS-offspring (200/500 mg/ kg) compared with control offspring (P < .05; Figure 3C ), but not in PND60 PFBS-offspring (200/500 mg/kg) (P > .05). The levels of hypothalamic GnRH (P > .05; Figure 3D ) in PND30 and PND60 PFBS-offspring (200/500 mg/kg) did not differ significantly from those in control offspring. In addition, PND60 PFBS-offspring (200/500 mg/kg) exhibited lower serum P4 levels at diestrus than control offspring (P < .05; Figure 3E ).
Prenatal Exposure to PFBS Causes Long-Term Hypothyroxinemia
We measured hypothalamic-pituitary-thyroid hormone levels in neonatal (PND1, n ¼ 30/10), pubertal (PND30, n ¼ 10/10), and adult (PND60, n ¼ 10/10) PFBS-offspring. Postnatal day 1 PFBSoffspring (200/500 mg/kg) (total T3: P < .01; Figure 4A ; total T4: P < .01; Figure 4B ), PND30 PFBS-offspring (200/500 mg/kg) (P < .01) and PND60 PFBS-offspring (200/500 mg/kg) (P < .05) exhibited significantly reduced serum total T3 and T4 levels compared with control offspring. Postnatal day 60 PFBS-offspring (200/ 500 mg/kg) exhibited a lower percentage decrease (23%) in total T4 levels than PND30 PFBS-offspring (200/500 mg/kg) (42%). In addition, PND30 PFBS-offspring (200/500 mg/kg) exhibited slight but significant elevations in serum TSH (P < .05; Figure 4C ) and hypothalamic Trh mRNA levels (P < .05; Figure 4D ) compared with control offspring. Although PND60 PFBS-offspring (200/ 500 mg/kg) tended to exhibit elevated TSH levels compared with control offspring, this difference failed to reach statistical significance (P > .05).
Exposure to PFBS during Gestation Reduces Thyroid Hormone Levels in Dams
Oral administration of PFBS (50, 200, and 500 mg/kg/day) in the pregnant mice on GD1-20 led to a dose-dependent increase in the levels of serum PFBS (control: 1.73 6 0.65 ng/ml; 50: 74.01 6 22.52 ng/ml; 200: 332.41 6 53.04 ng!/ml; 500:
720.86 6 98.4 ng/ml, n ¼ 10 dams; Table 3 ). The BWs of GD20 PFBS-dams were not different from those of control dams, irrespective of dosage (P > .05, n ¼ 10 dams; Table 3 ). To determine whether PFBS exposure during gestation reduces maternal thyroid hormone levels, leading to neonatal hypothyroxinemia, we examined thyroid hormone levels in GD20 dams. Compared with control dams, PFBS-dams (200/500 mg/kg) exhibited significantly reduced total T4 (P < .05, n ¼ 8 dams; Table 3 ), total T3 (P < .05, n ¼ 8 dams), and free T4 (P < .05, n ¼ 8 dams) levels, as well as increased TSH levels (P < .05, n ¼ 8 dams). The levels of serum E2 and P4 or hypothalamic GnRH in PFBS-dams did not differ significantly from those of control mice (P > .05, n ¼ 8 dams). 
DISCUSSION
The present study has provided evidence that prenatal exposure to PFBS (!200 mg/kg/day) causes permanent hypothyroxinemia accompanied by deficits in perinatal growth, pubertal onset, and reproductive organ development with low reproductive hormones in female offspring. In addition, the treatment of dams with PFBS (!200 mg/kg/day) during pregnancy leads to a significant decrease in the circulating thyroid hormones. PFBS has been demonstrated to have a much fast serum elimination rate due to its short perfluorinated chain and/or high percentage of free PFBS concentration in serum (KerstnerWood et al., 2003) . For example, the mean level of serum PFBS concentration at 24 h after a single oral administration of 30-mg PFBS/kg BW were 20 ng/ml in female rats and 380 ng/ml in male rats (Olsen et al., 2009) . In female monkeys, the level of serum PFBS concentration at 24 h after a single injection (IV) of 10 mg PFBS/kg BW was 9.56 6 4.91 lg/ml. In this study, the pregnant mice were daily treated with the oral administration of PFBS on GD1-20. The serum PFBS concentration at 12 h after the lastapplication of 50 mg/kg PFBS was 74.01 6 22.52 ng/ml. This result indicates further that PFBS might have a rapid elimination kinetic in the pregnant mice. In addition, the serum PFBS concentrations at 12 h after the last-application of 200 and 500 mg/kg PFBS were 332.41 6 53.04 ng/ml and 720.86 6 98.4 ng/ml, respectively. Olsen et al. (2009) reported that the mean serum PFBS concentration of employees engaged in PFBS production was 397 ng/ml (range, 92-921 ng/ml). Although these estimates may not represent the same active processes between species, they do allow comparison of serum PFBS concentrations. Our results showed that the serum PFBS levels in the pregnant mice exposed to 200 and 500 mg/kg/day PFBS for 20 days equivalent to those of employees engaged in PFBS production.
Prenatal exposure to PFBS (200/500 mg/kg) caused obvious decreases in total T4 and T3 levels in neonatal mice that were not associated with changes in TSH and Trh mRNA levels. GD20 dams exposed to PFBS (200/500 mg/kg) also exhibited decreases in total T4 and T3 levels and free T4 levels, when TSH levels increased. Maternal T4 can cross the placenta and can be converted to T3 before the fetus produces its own thyroid hormones. The developing fetus is completely dependent on maternal thyroid hormones because fetal thyroid function does not develop before the second trimester of pregnancy (Gilbert et al., 2012) . However, even after fetal thyroid hormone production onset, the maternal circulation serves as the primary source of thyroid hormones for the conceptus (de Escobar et al., 2004) . Similarly, prenatal exposure to PFOS has been reported to significantly reduce total and free T4 levels in neonatal rats (Yu et al., 2009a) . It is possible that decreases in thyroid hormone levels in PFBS-dams lead to decreases in thyroid hormone levels in PFBS-offspring. In addition, fetal thyroid follicle development and T4 synthesis coincide with hypothalamic-pituitary-thyroid axis activation, which depends on the placental system facilitating the transfer of maternal plasma iodide and the deiodination of T4 (Forhead and Fowden, 2014) . There is a strong association between maternal free T4 levels during pregnancy and newborn and childhood T4 levels, indicating that childhood thyroid function and development is regulated primarily by maternal free T4 levels (Korevaar et al., 2016) . The aforementioned decreases in thyroid hormones in PFBS (200/500 mg/kg)-offspring persisted until the pubertal and adult periods, as did the increases in TSH levels. A possible explanation is that decreases in thyroid hormone levels in PFBS-dams may impair thyroid development in offspring, leading to permanent hypothyroxinemia. In addition, the percent difference of total T4 levels between PND60 PFBS-offspring (200/500 mg/kg) and control offspring seems to be decreased in comparison with PND30 PFBSoffspring (200/500 mg/kg). Some previous reports indicate that E2 enhances the thyroid cell proliferation and increases the thyroid hormone biosynthesis (Lima et al., 2006) . Because the actual levels of the total T4 and T3 in PND60 PFBS-offspring (200/ 500 mg/kg) failed to be elevated compared with PND30 PFBS-offspring (200/500 mg/kg), thus it is likely that the decline of total T4 levels in PND60 control offspring decreases the percent difference from PND60 PFBS-offspring.
Although neonatal PFBS-offspring were born alive and appeared to be active, their BWs were lower than those of control offspring. In addition, PFBS-offspring exhibited postnatal growth retardation and developmental delay, as demonstrated by delays in eye opening. The importance of thyroid hormones for embryogenesis and fetal development is well-established (Burrow et al., 1994) . Growth retardation in pups may be an indirect effect of thyroid disruption (Rodriguez and Sanchez, 2010) . The exposure to PFOS has been reported to suppress the biosynthesis of E2 (Feng et al., 2015) . E2 is known to play an Data are expressed as the mean 6 SE.
*P < 0.05 and **P < 0.01 versus control mice (1-way ANOVA).
essential role in fetal development and maturation by potently stimulating fetal ACTH (Wood and Saoud, 1997) and TSH secretion (Banu et al., 2001) . However, neonatal PFBS-offspring did not exhibit changes in their E2 and TSH levels compared with control offspring. Moreover, delayed vaginal opening and first estrus, which are pubertal landmarks, were observed in PFBSoffspring. Perfluorobutanesulfonate-offspring exhibited a prolongation of diestrus. Similar with these findings, Lieder et al. (2009b) reported that perinatal exposure to 100 mg/kg/day PFBS causes a significant increase in the duration of diestrus in rats (!6 consecutive days), although the adverse effects exerted by 1000 mg/kg/day PFBS were significantly less severe than those exerted by 100 mg/kg/day PFBS. Estrous cycles are controlled by GnRH and LH release, which is regulated by E2 feedback. E2 levels in PND30 and PND60 PFBS-offspring were lower than in control offspring, but GnRH levels did not change. In addition, LH in PND30 PFBS-offspring was higher than that in control offspring. Prepubertal thyroid hormone insufficiency reportedly delays puberty onset and sexual maturity in female rats and humans. Hypothyroxinemia affects menstrual cycle duration and amount of menstrual bleeding (Krassas et al., 1999) . Hypothyroidism is associated with altered menstrual and estrous cycles in adult female humans and rats (Hapon et al., 2010; Krassas, 2000) although it does not affect the levels of serum LH and E2 (Armada-Dias et al., 2001) .
Our results indicate that prenatal exposure to PFBS can affect female reproductive development and function, as suggested by the following results. (1) Ovary size and number of follicles were significantly decreased in adult PFBS-offspring compared with control offspring. The thyroid hormone receptor in the ovarian surface epithelium is involved in the regulation of follicular development (Wakim et al., 1994) . Postnatal hypothyroid rats exhibit impaired ovarian follicular development (Tohei, 2004) . Fedail et al. (2014) reported that hypothyroxinemia significantly reduced the total numbers of primordial, primary, secondary and antral follicles in neonatal and immature rats.
(2) Adult PFBS-offspring exhibited fewer corpora lutea and lower P4 levels than control offspring. The follicle, the functional unit of the ovary, serves to protect and nourish the growing oocyte from the time of follicle formation to ovulation. The corpora lutea were smaller in number and diameter in adult hypothyroid rats (Armada-Dias et al., 2001) . Thus, it is proposed that impaired ovarian follicular development adversely affects ovulation. In addition, thyroid hormone insufficiency has been reported to inhibit the production of preovulatory LH surge in female rats, thereby affecting ovulation (Tamura et al., 1998) . (3) Uterine size was smaller in adult PFBS-offspring than in control offspring. Pubertal hypothyroidism can impair reproductive tract development in females (Longcope, 2000) . Armada-Dias et al. (2001) reported that even after puberty, hypothyroidism in adult rats caused a significant impairment in the weight of uterus and ovary. A previous study reported that the absolute volumes of the endometrium and muscle layer in the uteri of hypothyroid rats are significantly reduced via DNA transcription downregulation (Inuwa and Williams, 1996) . In addition, E2 can increase uterine size (Marzieh et al., 2015) via tissue hypertrophy rather than tissue hyperplasia (Johnson et al., 1997) . Therefore, whether the prenatal exposure to PFBS affects the female reproductive development and function by reducing thyroid hormone levels or E2 reduction should be an interesting subject for future work.
The present study has provided evidence that prenatal exposure to PFBS (!200 mg/kg/day) affects perinatal growth, pubertal onset, and reproductive organ development and causes permanent hypothyroxinemia in female mice. Perfluorobutanesulfonate production and use are being expanded; thus, it is important to determine the adverse effects of prenatal PFBS exposure on women's reproductive health and thyroid function.
